ZIOPOD^®-CV 325 is a combination of Cefpodoxime Proxetil 200 mg and Potassium Clavulanate 125 mg. This formulation enhances the antibacterial spectrum of cefpodoxime, making it highly effective against a broad range of bacterial infections. Clavulanate helps prevent bacterial resistance, ensuring improved efficacy in treating respiratory, urinary, and skin infections.

Usages of ZIOPOD^®-CV

• Treatment of respiratory tract infections, including pneumonia and bronchitis.
• Effective against complicated urinary tract infections (UTIs).
• Used in skin and soft tissue infections caused by bacterial pathogens.
• Helps in managing severe throat infections, such as tonsillitis and pharyngitis.

Benefits of ZIOPOD^®-CV

• Combination of cefpodoxime and clavulanate enhances antibacterial activity.
• Effective against both Gram-positive and Gram-negative bacterial strains.
• Prevents bacterial resistance for better treatment outcomes.
• Fast-acting formulation for quicker relief and recovery.

Possible Side Effects of ZIOPOD^®-CV

• Common side effects may include nausea, vomiting, and diarrhea.
• Some patients may experience abdominal discomfort or bloating.
• Rare allergic reactions such as skin rashes, itching, or swelling.
• Seek medical attention in case of severe reactions or persistent diarrhea.

Leading PCD Pharma Manufacturer – Amcare Pharmaceuticals

Amcare Pharmaceuticals is a leading manufacturer of ZIOPOD^®-CV, offering high-quality Cefpodoxime Proxetil 200 mg + Potassium Clavulanate 125 mg under its trusted brand name. With a commitment to innovation and stringent quality standards, we ensure top-notch formulations for effective patient care. As a reputed name in the pharmaceutical sector, we provide excellent business opportunities through our PCD Pharma franchise model. Contact us today to collaborate with us and expand your pharmaceutical business.